Showing 7 RESULTS FOR
Schizophrenia
Research Update: Tackling Schizophrenia’s Most Debilitating Symptoms
Lundbeck's Dr. Bruce Kinon on the challenges related to treating negative symptoms of schizophrenia and new directions in negative-symptom research.
The Hunt for Schizophrenia Biomarkers
By Bruce Kinon, MD
To date, no reliable biomarkers for schizophrenia have been identified. A new consortium hopes to change that.
Lundbeck Initiates Phase II Study of Potential New Treatment of Schizophrenia
Lu AF11167 represents a new approach to treat negative symptoms of schizophrenia, which is currently a huge unmet medical need.
Data Demonstrate Safety and Efficacy of Brexpiprazole in Patients With Schizophrenia Experiencing Severe Psychotic Symptoms
Study on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. Severity of symptoms can be a significant predictor of poor treatment outcomes.
Video: No Stone Unturned in Mental Health Research
By Doug Williamson, MD
In this video, Dr. Doug Williamson, Lundbeck's Chief Medical Officer and VP of US Medical, discusses putting patients at the center of drug R&D and how Lundbeck is leaving no stone unturned in pursuit of new treatment options.